INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited – RGC

NEW YORK CITY, NY / ACCESS Newswire / December 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ:RGC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Regencell and certain of its officers […]

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors With Losses on Their Investment in Wildermuth Fund of Class Action Lawsuit And Upcoming Deadlines – WESFX; WEFCX; WEIFX

NEW YORK CITY, NY / ACCESS Newswire / December 4, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Class A, Class C, and/or Class I shares in the Wildermuth Fund (the "Fund") (NASDAQ:WESFX; WEFCX; WEIFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alibaba Group Holding Limited – BABA

NEW YORK CITY, NY / ACCESS Newswire / December 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Alibaba Group Holding Limited ("Alibaba" or the "Company") (NYSE:BABA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Alibaba and certain of its officers

New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer’s Pathobiology

Exploring GLP-1 drugs as preventive therapy may still hold promise within broader strategy targeting Alzheimer's pathways beyond amyloid, ADDF notes Today, Novo Nordisk presented new topline results from their Evoke and Evoke+ phase 3 trials of semaglutide, an oral GLP-1 drug, at the Clinical Trials on Alzheimer's Disease (CTAD) conference. While the trials did not

Portnoy Law Firm Announces Class Action on Behalf of Freeport-McMoran, Inc. Investors

(NYSE:FCX), LOS ANGELES, Dec. 04, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Freeport-McMoran, Inc., (“Freeport” or the “Company”) (NYSE: FCX) investors off a class action on behalf of investors that bought securities between February 15, 2022 and September 24, 2025, inclusive (the “Class Period”). Freeport investors have until January 12, 2026 to file

NAVA to Honor Voice of Goofy and Pluto Bill Farmer As VO Icon Award Winner at Annual Gala

LOS ANGELES, Dec. 04, 2025 (GLOBE NEWSWIRE) — The National Association of Voice Actors (NAVA) Foundation, a social impact non-profit dedicated to advancing the voice acting industry, today announced that Bill Farmer, the legendary performer who has voiced Goofy since 1987 and Pluto since 1990, will receive this year's VO Icon Award at its annual

Excellence in Action: AUA Reveals 2026 Distinguished Award Winners

BALTIMORE, Dec. 04, 2025 (GLOBE NEWSWIRE) — The American Urological Association (AUA) announced today the list of 2026 award recipients. The winners will be recognized at the Association's Annual Meeting in Washington, D.C, next May. The ceremony will celebrate physician researchers and educators for their contributions to the field of medicine, the specialty of urology,

Cleanroom Technologies Market Surges Toward US$10.58 Billion by 2031, Driven by Semiconductor Expansion and Biopharma Sterile Manufacturing

According to DataM Intelligence, the Global Cleanroom Technologies Market Size reached an estimatedUS$6.53 billion in 2024and is projected to climb steadily toUS$10.58 billion by 2031, registering aCAGR of 7.14%during the forecast period. The rise of advanced sterile production systems, tighter global GMP regulations, and accelerated investments in wafer-level chip manufacturing have positioned clean room technologies

Vector Database Market $ 8,945.7 million by 2030 | MarketsandMarkets™

According to MarketsandMarkets™, the Vector Database Market is expected to be worth USD 2,652.1 million in 2025 and reach USD 8,945.7 million by 2030, growing at a compound annual growth rate (CAGR) of 27.5% during the forecast period. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse180 market data Tables and120 Figures spread through310 Pages and in-depth TOC on”Vector Database Market –

C2MS’s Safety Armor set to leverage generative and agentic AI from Smartsheet

Centurion Construction Management Solutions (C2MS)and its comprehensive construction safety management system, Safety Armor, are poised to take a major leap forward by leveraging Smartsheet's latest generative and agentic AI capabilities. These advancements will drive measurable improvements in worker safety, operational efficiency, and predictive risk management. https://mma.prnewswire.com/media/2588772/C2MS_Logo.jpg Scott Wuestner, Founder and CEO of C2MS stated, “With

Scroll to Top